Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-21-058522
Filing Date
2021-04-30
Accepted
2021-04-30 11:33:17
Documents
3
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2114361d1_10ka.htm 10-K/A 84024
2 EXHIBIT 31.1 tm2114361d1_ex31-1.htm EX-31.1 9063
3 EXHIBIT 31.2 tm2114361d1_ex31-2.htm EX-31.2 9067
  Complete submission text file 0001104659-21-058522.txt   103161
Mailing Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032
Business Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

EIN.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38630 | Film No.: 21875175
SIC: 2834 Pharmaceutical Preparations